BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Diagnosis
682 results:

  • 1. Evolutionary trajectories of small cell lung cancer under therapy.
    George J; Maas L; Abedpour N; Cartolano M; Kaiser L; Fischer RN; Scheel AH; Weber JP; Hellmich M; Bosco G; Volz C; Mueller C; Dahmen I; John F; Alves CP; Werr L; Panse JP; Kirschner M; Engel-Riedel W; Jürgens J; Stoelben E; Brockmann M; Grau S; Sebastian M; Stratmann JA; Kern J; Hummel HD; Hegedüs B; Schuler M; Plönes T; Aigner C; Elter T; Toepelt K; Ko YD; Kurz S; Grohé C; Serke M; Höpker K; Hagmeyer L; Doerr F; Hekmath K; Strapatsas J; Kambartel KO; Chakupurakal G; Busch A; Bauernfeind FG; Griesinger F; Luers A; Dirks W; Wiewrodt R; Luecke A; Rodermann E; Diel A; Hagen V; Severin K; Ullrich RT; Reinhardt HC; Quaas A; Bogus M; Courts C; Nürnberg P; Becker K; Achter V; Büttner R; Wolf J; Peifer M; Thomas RK
    Nature; 2024 Mar; 627(8005):880-889. PubMed ID: 38480884
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Oral carcinogenesis and non-invasive biomarkers for the diagnosis of oral squamous cell carcinoma.
    Khan S; Alamgir MM
    J Pak Med Assoc; 2024 Feb; 74(2):370-373. PubMed ID: 38419239
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Deep response to a combination of mTOR inhibitor temsirolimus and dual immunotherapy of nivolumab/ipilimumab in poorly differentiated thyroid carcinoma with
    Oh Y; Park JH; Djunadi TA; Shah Z; Chung LI; Chae YK
    Front Endocrinol (Lausanne); 2024; 15():1304188. PubMed ID: 38356955
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinical value of multi-gene testing in distinguishing benign and malignant thyroid nodules.
    Zhang M; Hu X; Liu L; Wang Y; Jiang J; Li H; Fei W; Zhong T; Jiang Z
    Medicine (Baltimore); 2024 Jan; 103(4):e35960. PubMed ID: 38277563
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Development and validation of glycosyltransferase related-gene for the diagnosis and prognosis of head and neck squamous cell carcinoma.
    He M; Wang L; Yue Z; Feng C; Dai G; Jiang J; Huang H; Ji Q; Zhou M; Li D; Chai W
    Aging (Albany NY); 2024 Jan; 16(2):1750-1766. PubMed ID: 38244579
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Gene mutation analysis of oral submucous fibrosis cancerization in Hainan Island.
    Li B; Chen X; Xian H; Wen Q; Wang T
    PeerJ; 2023; 11():e16392. PubMed ID: 38050610
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. An emerging biomarker for the diagnosis and treatment of esophageal squamous cell carcinoma - Aurora A.
    Zhou W; Guo S; Zhang J; Yan Y; Wu J; Liu X
    Comput Biol Med; 2024 Jan; 168():107759. PubMed ID: 38043467
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Decoding the role of miRNAs in oral cancer pathogenesis: A focus on signaling pathways.
    Doghish AS; El-Husseiny AA; Khidr EG; Elrebehy MA; Elballal MS; Abdel-Reheim MA; Abdel Mageed SS; Zaki MB; Mohammed OA; Khaled R; El-Dakroury WA; Noureldin S; Moustafa YM; Mangoura SA; Gedawy EM; Abulsoud AI
    Pathol Res Pract; 2023 Dec; 252():154949. PubMed ID: 37992507
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Divergent Lineage Markers in Anaplastic Thyroid Carcinoma.
    Mneimneh WS; Asa SL
    Am J Surg Pathol; 2024 Feb; 48(2):230-237. PubMed ID: 37972932
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Characterization of the Thyroid cancer Genomic Landscape by Plasma-Based Circulating Tumor DNA Next-Generation Sequencing.
    Tarasova VD; Tsai J; Masannat J; Hernandez Prera JC; Hallanger Johnson J; Veloski C; Agosto Salgado S; McIver B; Drusbosky LM; Chung CH
    Thyroid; 2024 Feb; 34(2):197-205. PubMed ID: 37962267
    [No Abstract]    [Full Text] [Related]  

  • 11. Clear Cell Squamous Cell Carcinoma of the Maxillary Gingiva Associated with PIK3CA and HRAS Mutations: Report of a Case and Literature Review.
    Hirose K; Shibahara T; Teramoto A; Usami Y; Ono S; Iwamoto Y; Murakami S; Oya K; Uzawa N; Motooka D; Hori Y; Morii E; Toyosawa S
    Head Neck Pathol; 2023 Dec; 17(4):1026-1033. PubMed ID: 37735286
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Molecular Factors in Carcinoma Ex Pleomorphic Adenoma: Systematic Review and Meta-Analysis.
    Key S; Chia C; Hasan Z; Sundaresan P; Riffat F; Dwivedi RC
    Laryngoscope; 2024 Mar; 134(3):1042-1053. PubMed ID: 37610148
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Use of Immunohistochemical p53 Mutant-Phenotype in diagnosis of High-Grade Dysplasia of Esophageal Squamous Epithelia.
    Xu YJ; Li R; Chen JM; Zhuang XY; Lin N; Wang LP; Zeng BW
    Dig Dis; 2023; 41(5):685-694. PubMed ID: 37579733
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. DICER1 Mutations Do Not Always Indicate Dismal Prognosis in Pediatric Poorly Differentiated Thyroid Carcinomas.
    Yegen G; Altay AY; Yılmaz İ; İşcan Y; Sormaz İC; Aksakal N; Önder S; Mete Ö
    Endocr Pathol; 2023 Sep; 34(3):279-286. PubMed ID: 37574466
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A new method for oral cancer biomarkers detection with a non-invasive cyto-salivary sampling and rapid-highly sensitive ELISA immunoassay: a pilot study in humans.
    Rebaudi F; De Rosa A; Greppi M; Pistilli R; Pucci R; Govoni FA; Iacoviello P; Broccolo F; Tomasello G; Pesce S; Laganà F; Bianchi B; Di Gaudio F; Rebaudi A; Marcenaro E
    Front Immunol; 2023; 14():1216107. PubMed ID: 37483588
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Esophageal carcinoma with SMARCA4 mutation: Unique diagnostic challenges.
    Cui M; Lemmon K; Jin Z; Uboha NV
    Pathol Res Pract; 2023 Aug; 248():154692. PubMed ID: 37459679
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The many faces of Atypical fibroxanthoma.
    Agaimy A
    Semin Diagn Pathol; 2023 Jul; 40(4):306-312. PubMed ID: 37438163
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinical and pathological features of second primary neoplasms arising in head and neck reconstructive skin flaps.
    Eguchi K; Kobayashi K; Honma Y; Ryo E; Sakyo A; Yokoyama K; Watanabe T; Aihara Y; Sakai A; Matsumoto Y; Sakai T; Omura G; Yatabe Y; Yoshimoto S; Mori T
    Sci Rep; 2023 Jul; 13(1):11214. PubMed ID: 37433786
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Using Proteome Microarray and Gene Expression Omnibus Database to Screen Tumour-Associated Antigens to Construct the Optimal Diagnostic Model of Oesophageal Squamous Cell Carcinoma.
    Sun G; Ye H; Yang Q; Zhu J; Qiu C; Shi J; Dai L; Wang K; Zhang J; Wang P
    Clin Oncol (R Coll Radiol); 2023 Oct; 35(10):e582-e592. PubMed ID: 37433700
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Data mining on identifying diagnosis and prognosis biomarkers in head and neck squamous carcinoma.
    Ju G; Yao Z; Zhao Y; Zhao X; Liu F
    Sci Rep; 2023 Jun; 13(1):10020. PubMed ID: 37340028
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 35.